CVC Capital Partners has acquired a 50% stake in Germany-based DFE Pharma, a manufacturer of excipients for the pharmaceutical industry, from New Zealand-listed dairy company Fonterra for NZD 633m (€363m).
DVI Equity Partners, Frontline Ventures and Enterprise Ireland also take part
Newcomer Target Global and existing investor Round Hill Ventures also take part in the round
GP invests €7.3m in the France-based point-of-sale merchandising equipment provider
Azimut appoints Jeffry Brown as CEO of AACP; Brown previously worked at Dyal Capital Partners